In 2010, John Knox Singleton, the CEO of the Inova Health System, had several meetings with John Niederhuber, a surgeon and scientist who had just been replaced as NCI director.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
